Experimental studies suggest that monocytic differentiation is also associated with resistance to CDK4/6 inhibitors [23], whereas monocytic AML shows relatively high responsiveness to bromodomain inhibitors [23]. This evidence concerns the gene CDK4 and acute myeloid leukemia.